SUNRESTPharmaceuticals
Sunrest Lifescience Ltd — Cash Flow Statement
₹37.00
-15.03%
Sunrest Lifescience Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 0.06 Cr | -14.80 Cr | 1.14 Cr | -0.92 Cr | — |
| Repayment Of Debt | -0.06 Cr | 0.00 | -1.10 Cr | 0.00 | — |
| Issuance Of Debt | 0.04 Cr | 4.02 Cr | 0.00 | 0.92 Cr | — |
| Capital Expenditure | -1.37 Cr | -71000.00 | -0.01 Cr | -0.47 Cr | — |
| End Cash Position | 0.25 Cr | 0.29 Cr | 0.45 Cr | 0.48 Cr | — |
| Other Cash Adjustment Outside Changein Cash | -1000.00 | -1000.00 | — | — | — |
| Beginning Cash Position | 0.29 Cr | 0.45 Cr | 0.48 Cr | 0.37 Cr | — |
| Changes In Cash | -0.04 Cr | -0.16 Cr | -0.03 Cr | 0.11 Cr | — |
| Financing Cash Flow | -0.33 Cr | 14.64 Cr | -1.15 Cr | 0.91 Cr | — |
| Net Other Financing Charges | 12000.00 | — | — | — | 1000.00 |
| Interest Paid Cff | -0.31 Cr | -0.22 Cr | -0.06 Cr | -0.01 Cr | — |
| Net Issuance Payments Of Debt | -0.02 Cr | 4.02 Cr | -1.10 Cr | 0.92 Cr | — |
| Net Long Term Debt Issuance | -0.02 Cr | 4.02 Cr | -1.10 Cr | 0.92 Cr | — |
| Long Term Debt Payments | -0.06 Cr | 0.00 | -1.10 Cr | 0.00 | — |
| Long Term Debt Issuance | 0.04 Cr | 4.02 Cr | 0.00 | 0.92 Cr | — |
| Investing Cash Flow | -1.15 Cr | -71000.00 | -0.03 Cr | -0.36 Cr | — |
| Net Investment Purchase And Sale | 0.02 Cr | 0.00 | -0.02 Cr | 0.00 | — |
| Sale Of Investment | 0.02 Cr | 0.00 | 0.00 | — | — |
| Net PPE Purchase And Sale | -1.16 Cr | -71000.00 | -0.01 Cr | -0.36 Cr | — |
| Sale Of PPE | 0.21 Cr | 0.00 | 0.00 | 0.11 Cr | — |
| Purchase Of PPE | -1.37 Cr | -71000.00 | -0.01 Cr | -0.47 Cr | — |
| Operating Cash Flow | 1.43 Cr | -14.80 Cr | 1.15 Cr | -0.45 Cr | — |
| Taxes Refund Paid | -0.48 Cr | -0.84 Cr | -0.38 Cr | -0.08 Cr | — |
| Interest Received Cfo | 34000.00 | — | — | — | — |
| Change In Working Capital | -0.11 Cr | -14.87 Cr | -1.40 Cr | -1.47 Cr | — |
| Change In Other Current Liabilities | 0.10 Cr | -1.24 Cr | 1.49 Cr | -0.01 Cr | — |
| Change In Other Current Assets | 37000.00 | -39000.00 | 0.00 | 0.00 | — |
| Change In Payable | 9.05 Cr | -4.82 Cr | 0.69 Cr | 1.52 Cr | — |
| Change In Inventory | -2.09 Cr | -1.11 Cr | -1.65 Cr | -0.77 Cr | — |
| Change In Receivables | -7.25 Cr | -7.45 Cr | -2.06 Cr | -2.20 Cr | — |
| Other Non Cash Items | 0.30 Cr | 0.22 Cr | 0.06 Cr | 0.01 Cr | — |
| Depreciation And Amortization | 0.10 Cr | 0.10 Cr | 0.13 Cr | 0.06 Cr | — |
| Depreciation | 0.10 Cr | 0.10 Cr | 0.13 Cr | 0.06 Cr | — |
| Gain Loss On Sale Of PPE | 4000.00 | — | 0.00 | -0.02 Cr | 0.00 |
| Net Income From Continuing Operations | 1.62 Cr | 0.59 Cr | 2.74 Cr | 1.05 Cr | — |
| Issuance Of Capital Stock | — | 10.85 Cr | 0.00 | — | — |
| Common Stock Dividend Paid | — | 0.00 | 0.00 | — | — |
| Net Common Stock Issuance | — | 10.85 Cr | 0.00 | — | — |
| Common Stock Issuance | — | 10.85 Cr | 0.00 | — | — |
| Interest Received Cfi | — | 0.00 | 0.00 | — | — |
| Dividends Received Cfi | — | 0.00 | 0.00 | — | — |
| Purchase Of Investment | — | 0.00 | -0.02 Cr | 0.00 | — |
| Capital Expenditure Reported | — | 0.00 | 0.00 | — | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Sunrest Lifescience Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.